Arthur Raymond Hubert van Zanten

Arthur Raymond Hubert van Zanten

Top Cited Scholar 2025
Auto-generated profile, based on publicly available information

Arthur Raymond Hubert van Zanten


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Clinical Nutrition
Verified
Journal Article
Closed access
PSPierre Singer
Pierre Singer
ABAnnika Reintam Blaser
Annika Reintam Blaser
MBMette M. Berger
Mette M. Berger
WAWaleed Alhazzani
Waleed Alhazzani
PCPhilip Calder
Philip Calder
SBStephan C. Bischoff
Stephan C. Bischoff

14 July 2023 in Clinical Nutrition
Verified
Journal Article
Closed access
PSPierre Singer
Pierre Singer
ABAnnika Reintam Blaser
Annika Reintam Blaser
MBMette M. Berger
Mette M. Berger
PCPhilip Calder
Philip Calder
MCMichael Casaer
Michael Casaer
SBStephan C. Bischoff
Stephan C. Bischoff

6 February 2017 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
EFESICM Working Group on Gastrointestinal Function
ESICM Working Group on Gastrointestinal Function
ABAnnika Reintam Blaser
Annika Reintam Blaser
JSJoel Starkopf
Joel Starkopf
WAWaleed Alhazzani
Waleed Alhazzani
MBMette M. Berger
Mette M. Berger
HSHeleen M. Oudemans-Van Straaten
Heleen M. Oudemans-Van Straaten
Purpose To provide evidence-based guidelines for early enteral nutrition (EEN) during critical illness. Methods We aimed to compare EEN vs. early parenteral nutrition (PN) and vs. delayed EN. We defined “early” EN as EN started within 48 h independent of type or amount. We listed, a priori, conditions in which EN is often delayed, and performed systematic reviews in 24 such subtopics. If sufficient evidence was available, we performed meta-analyses; if not, we qualitatively summarized the evidence and based our recommendations on expert opinion. We used the GRADE approach for guideline development. The final recommendations were compiled via Delphi rounds. Results We formulated 17 recommendations favouring initiation of EEN and seven recommendations favouring delaying EN. We performed five meta-analyses: in unselected critically ill patients, and specifically in traumatic brain injury, severe acute pancreatitis, gastrointestinal (GI) surgery and abdominal trauma. EEN reduced infectious complications in unselected critically ill patients, in patients with severe acute pancreatitis, and after GI surgery. We did not detect any evidence of superiority for early PN or delayed EN over EEN. All recommendations are weak because of the low quality of evidence, with several based only on expert opinion. Conclusions We suggest using EEN in the majority of critically ill under certain precautions. In the absence of evidence, we suggest delaying EN in critically ill patients with uncontrolled shock, uncontrolled hypoxaemia and acidosis, uncontrolled upper GI bleeding, gastric aspirate >500 ml/6 h, bowel ischaemia, bowel obstruction, abdominal compartment syndrome, and high-output fistula without distal feeding access.

29 January 2015 in Critical Care
Verified
Journal Article
Open access
PDF file
Jean Charles PreiserJean Charles Preiser
Jean Charles Preiser
AZArthur Rh van Zanten
Arthur Rh van Zanten
MBMette M. Berger
Mette M. Berger
GBGianni Biolo
Gianni Biolo
MCMichael P Casaer
Michael P Casaer
JVJean-Louis Vincent
Jean-Louis Vincent
The results of recent large-scale clinical trials have led us to review our understanding of the metabolic response to stress and the most appropriate means of managing nutrition in critically ill patients. This review presents an update in this field, identifying and discussing a number of areas for which consensus has been reached and others where controversy remains and presenting areas for future research. We discuss optimal calorie and protein intake, the incidence and management of re-feeding syndrome, the role of gastric residual volume monitoring, the place of supplemental parenteral nutrition when enteral feeding is deemed insufficient, the role of indirect calorimetry, and potential indications for several pharmaconutrients.

29 April 2016 in Critical Care
Verified
Journal Article
Open access
PDF file
GEGunnar Elke
Gunnar Elke
AZArthur R. H. van Zanten
Arthur R. H. van Zanten
MLMargot Lemieux
Margot Lemieux
MMMichele McCall
Michele McCall
KJKhursheed N. Jeejeebhoy
Khursheed N. Jeejeebhoy
Daren HeylandDaren Heyland
Daren Heyland
Enteral nutrition (EN) is recommended as the preferred route for early nutrition therapy in critically ill adults over parenteral nutrition (PN). A recent large randomized controlled trial (RCT) showed no outcome differences between the two routes. The objective of this systematic review was to evaluate the effect of the route of nutrition (EN versus PN) on clinical outcomes of critically ill patients. An electronic search from 1980 to 2016 was performed identifying relevant RCTs. Individual trial data were abstracted and methodological quality of included trials scored independently by two reviewers. The primary outcome was overall mortality and secondary outcomes included infectious complications, length of stay (LOS) and mechanical ventilation. Subgroup analyses were performed to examine the treatment effect by dissimilar caloric intakes, year of publication and trial methodology. We performed a test of asymmetry to assess for the presence of publication bias. A total of 18 RCTs studying 3347 patients met inclusion criteria. Median methodological score was 7 (range, 2–12). No effect on overall mortality was found (1.04, 95 % CI 0.82, 1.33, P = 0.75, heterogeneity I2 = 11 %). EN compared to PN was associated with a significant reduction in infectious complications (RR 0.64, 95 % CI 0.48, 0.87, P = 0.004, I2 = 47 %). This was more pronounced in the subgroup of RCTs where the PN group received significantly more calories (RR 0.55, 95 % CI 0.37, 0.82, P = 0.003, I2 = 0 %), while no effect was seen in trials where EN and PN groups had a similar caloric intake (RR 0.94, 95 % CI 0.80, 1.10, P = 0.44, I2 = 0 %; test for subgroup differences, P = 0.003). Year of publication and methodological quality did not influence these findings; however, a publication bias may be present as the test of asymmetry was significant (P = 0.003). EN was associated with significant reduction in ICU LOS (weighted mean difference [WMD] -0.80, 95 % CI −1.23, −0.37, P = 0.0003, I2 = 0 %) while no significant differences in hospital LOS and mechanical ventilation were observed. In critically ill patients, the use of EN as compared to PN has no effect on overall mortality but decreases infectious complications and ICU LOS. This may be explained by the benefit of reduced macronutrient intake rather than the enteral route itself.

21 November 2019 in Critical Care
Verified
Journal Article
Open access
PDF file
AZArthur Raymond Hubert van Zanten
Arthur Raymond Hubert van Zanten
EWElisabeth De Waele
Elisabeth De Waele
PWPaul Edmund Wischmeyer
Paul Edmund Wischmeyer
Background: Although mortality due to critical illness has fallen over decades, the number of patients with long-term functional disabilities has increased, leading to impaired quality of life and significant healthcare costs. As an essential part of the multimodal interventions available to improve outcome of critical illness, optimal nutrition therapy should be provided during critical illness, after ICU discharge, and following hospital discharge. Methods: This narrative review summarizes the latest scientific insights and guidelines on ICU nutrition delivery. Practical guidance is given to provide optimal nutrition therapy during the three phases of the patient journey. Results: Based on recent literature and guidelines, gradual progression to caloric and protein targets during the initial phase of ICU stay is recommended. After this phase, full caloric dose can be provided, preferably based on indirect calorimetry. Phosphate should be monitored to detect refeeding hypophosphatemia, and when occurring, caloric restriction should be instituted. For proteins, at least 1.3 g of proteins/kg/day should be targeted after the initial phase. During the chronic ICU phase, and after ICU discharge, higher protein/caloric targets should be provided preferably combined with exercise. After ICU discharge, achieving protein targets is more difficult than reaching caloric goals, in particular after removal of the feeding tube. After hospital discharge, probably very high-dose protein and calorie feeding for prolonged duration is necessary to optimize the outcome. High-protein oral nutrition supplements are likely essential in this period. Several pharmacological options are available to combine with nutrition therapy to enhance the anabolic response and stimulate muscle protein synthesis. Conclusions: During and after ICU care, optimal nutrition therapy is essential to improve the long-term outcome to reduce the likelihood of the patient to becoming a “victim” of critical illness. Frequently, nutrition targets are not achieved in any phase of recovery. Personalized nutrition therapy, while respecting different targets during the phases of the patient journey after critical illness, should be prescribed and monitored.